Today on Your Call: What do the Supreme Court's rulings on generics mean for consumers?

Jul 30, 2013

On today's Your Call, we'll have a conversation about two recent Supreme Court rulings. One deals with brand name companies paying competitors to delay the introduction of cheaper versions of their drugs. The second ruling shields manufacturers from liability for defective medicines. So what do the recent rulings mean for those of us who take generic drugs? It's Your Call, with Rose Aguilar and you. 


Emily Rusch, State Director at CalPIRG and consumer advocate. Her areas of focus include making healthcare more affordable and accessible. 

Jerry Avorn, Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham Young Women's Hospital. He studies the effects of prescription drugs and policy surrounding them.  He is the author of Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, now in its 11th printing.  

Web Resources:

Bloomberg: Consumers Win in Supreme Court's Pay-to-Delay Ruling

CalPIRG: Top Twenty Pay-for-Delay Drugs

InfoWars: Generic Drug Makers Granted Immunity Against Lawsuits From Patients Harmed by Side Effects

NYTimes: Healing the Overwhelmed Physician

Resources for understanding your medications: 

RxISK: Making Medicines Safer for All of Us 

Non-Profit drug information:

More information on medications: Powerful Medicines

Medication price comparison: GoodRx